291P Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study

291P Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 31; p. S358
Main Authors: Martinez-Garcia, J., Boix, A. Puertes, Henarejos, P. Sanchez, Lucas, M.D. Jimenez, Saura, A. Sanchez, Luengo, M., Vicente, R. Carrillo, Ortiz, M.J. Martinez, Balsalobre, J., Barrio, P.D.L.M. de la Morena, Garre, E. Garcia, Garcia, E., Marin, G., Torralba, E. Garcia, Ayala de la Pena, F., Collado, D., Lopez, A., Quiros, T., Sánchez, D.A., Romero, J.L.A.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2020.08.393